Correlation of Age and Paracetamol Administration with AEFI Reactions Post Moderna Vaccination at Puskesmas Mojosongo Boyolali
Keywords:
Moderna, Age, Paracetamol, AEFIAbstract
Many moderna vaccine recipients complain about the presence of AEFI (Adverse Events Following Immunization). Based on CDC data, the frequency of AEFI is higher in the 18-64 year age group. Some studies explain that minor AEFI reactions are managed with paracetamol and subside about 1-2 days after administration of the vaccine. This study aims to determine the relationship between age and administration of paracetamol with AEFI reactions after moderna vaccination at Puskesmas Mojosongo Boyolali. This study used an analytic observational survey research with a cross sectional research design which was carried out with quantitative methods. The data source used is primary data with a g-form questionnaire. This research was conducted at Puskesmas Mojosongo Boyolali, Central Java. The sampling technique in this study was non-random sampling with purposive sampling. The number of respondents is 72 people. The results of the logistic regression test of the relationship between age and AEFI reaction obtained the value of Exp(B) or OR=1.118 (p=0.883). Logistic regression test of the relationship between the administration of paracetamol with the AEFI reaction obtained the value of Exp (B) or OR = 1.949 (p = 0.452). The results of multivariate analysis showed that the variables of age and administration of paracetamol did not have a significant relationship with the reaction of AEFI after moderna vaccination.
References
[2] Kemenkes, “Situasi Terkini Perkembangan Coronavirus Disease (Covid-19), 2021 [Online], Available: https://covid19.who.int/
[3] CDC, “General Best Practice Guidelines for Immunization: Best Practices Guidance of the Advisory Committee on Immunization Practices (ACIP). Contraindications and Precautions.,” 2020.
[4] R. K. Joshi et al., “Higher incidence of reported adverse events following immunisation (AEFI) after first dose of COVID-19 vaccine among previously infected health care workers,” Medical Journal Armed Forces India. 2021, doi: 10.1016/j.mjafi.2021.05.011.
[5] M. Etminan, M. Sodhi, and S. Ganjizadeh-Zavareh, “Should Antipyretics Be Used to Relieve Acute Adverse Events Related to COVID-19 Vaccines?,” Chest. 2021, doi: 10.1016/j.chest.2021.01.080.
[6] D. Kamal, V. Thakur, N. Nath, T. Malhotra, A. Gupta, and R. Batlish, “Adverse events following ChAdOx1 nCoV-19 Vaccine (COVISHIELD) amongst health care workers: A prospective observational study,” Med. J. Armed Forces India, 2021, doi: 10.1016/j.mjafi.2021.06.014.
[7] D. E. McMahon et al., “Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases,” J. Am. Acad. Dermatol., 2021, doi: 10.1016/j.jaad.2021.03.092.
[8] M. Jeon, J. Kim, C. E. Oh, and J. Y. Lee, “Adverse Events Following Immunization Associated with Coronavirus Disease 2019 Vaccination Reported in the Mobile Vaccine Adverse Events Reporting System,” J. Korean Med. Sci., 2021, doi: 10.3346/jkms.2021.36.e114.
[9] R. Suparwati, H. Kartini, S. Atik, and P. K. Malang, “Perbedaan KIPI Pada Pemberian Parasetamol Sebelum dan Sesudah Imunisasi,” J. Kesehat. dr. SOEBANDI, 2018.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Syah Fillia Nurul Maslahah, Nining Lestari, Nida Faradisa Fauziyah, Siti Soekiswati
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
